Angela M. Cacace, Chief Scientific Officer at ARVINAS, INC. (ARVN), sold 4,592 shares at $11.89 ($55K) on 2026-02-13, disclosed to the SEC on 2026-02-18.
Open-market sale of $55k ARVN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARVN | SELL | 2026-02-25 | $44K | — | Filing → |
| ARVN | SELL | 2025-06-18 | $19K | — | Filing → |
| ARVN | SELL | 2025-02-25 | $122K | — | Filing → |